IDH1 and central nervous system cancer: Among the possibilities we note the interest to combine immunohistochemical analysis of other known prognostic factors in gliomas such as TP53, MGMT, EGFR and IDH1 expression with the chromosome 1p and 19q status within a given sub-population of tumor cells [9], [19], [34], [64], [65], [66].